Overview

MESS-study MRSA Eradication Study Skåne

Status:
Completed

Trial end date:
2015-05-01

Target enrollment:
0

Participant gender:
All

Summary

The purpose of this study is to determine whether systemic antibiotic treatment with rifampicin and clindamycine or trimethoprim-sulfa in addition to topical treatment with mupirocin is more effective than only topical treatment to eradicate MRSA in throatcarriers

Phase:

N/A

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Region Skane

Treatments:

Mupirocin
Rifampin
Trimethoprim, Sulfamethoxazole Drug Combination

Criteria

Inclusion Criteria:

Colonized with MRSA in the throat Older than 5 years MRSA-bacteria sensitive for Rifampicin
and Clindamycine or Trimethoprimsulfa -

Exclusion Criteria:

Allergy to the studymedication Healthcareworkers Pregnancy Active infection with MRSA
Immunosuppression Treatment with other antibiotic during the studyperiod